相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 保质期:
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 英文名:
Lansoprazole
- 库存:
现询
- 供应商:
北京索莱宝科技有限公司
- CAS号:
103577-45-3
- 规格:
1g/500mg
| 规格: | 1g | 产品价格: | ¥650.0 |
|---|---|---|---|
| 规格: | 500mg | 产品价格: | ¥490.0 |
是质子泵抑制剂。
| 基本信息 | |
| CAS | No.103577-45-3 |
| 中文名称 | 兰索拉唑 |
| 英文名称 | Lansoprazole |
| 别名 | 兰索拉唑;CV-11974-d4;兰索拉唑;南索拉唑; |
| 分子式 | C16H14F3N3O2S |
| 分子量 | 369.36 |
| 溶解性 | Soluble in DMSO ≥10mg/mL |
| 纯度 | HPLC≥98% |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
| EC | EINECS 2017-001-1 |
| MDL | MFCD00866873 |
| SMILES | O=S(C1=NC2=CC=CC=C2N1)CC3=NC=CC(OCC(F)(F)F)=C3C |
| InChIKey | MJIHNNLFOKEZEW-UHFFFAOYSA-N |
| InChI | InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22) |
| PubChem CID | 3883 |
| 靶点 | Proton Pump |
| 通路 | Membrane Transporter&Ion Channel |
| 背景说明 | Lansoprazole/AG-1749是质子泵抑制剂。 |
| 生物活性 | Lansoprazole is an orally active proton pump inhibitor which prevents the stomach from producing acid.Lansoprazole is a Proton Pump Inhibitor and agonist of liver x receptors.[1-2] |
| In Vitro | Lansoprazole inhibited gastric acid formation in acutely isolated gastric glands (IC??) values, 0.76 μM.[3] |
| 细胞实验 | After administration of lansoprazole for 4 days, no significant alteration in the terminal elimination half-life (t1/2beta) or the mean resistance time (MRT) was detected. However, there was a significant decrease of about 13% in the area under the plasma concentration-time curve (AUC) and a significant increase of about 19% in the apparent clearance (CLapp). Lansoprazole treatment for 11 days caused a significant decrease of approximately 12% in t1/2beta and about 10% in the MRT of theophylline, although neither AUC nor CLapp showed a significant alteration. The excretion of 3-MX in the urine was significantly increased by about 20% after lansoprazole treatment for 4 and 11 days, although there was no significant alteration in the excretion of unchanged theophylline, 1,3-DMU or 1-MU. [1]Lansoprazole treatment significantly attenuated STZ and HFD -induced memory deficits, biochemical and histopathological alterations. It also prevented HFD-induced rise in the Cholesterol level. Moreover, both cholesterol-dependent as well as cholesterol-independent effects of lansoprazole appear to play a role.[2] |
| 动物实验 | The effect of the new substituted benzimidizole Proton Pump Inhibitor, lansoprazole, on pharmacokinetics and metabolism of theophylline has been studied in healthy adults given oral lansoprazole 30 mg once daily for 11 days. On Days 4 and 11 of 300 mg aminophylline was simultaneously administered orally and blood samples for theophylline analysis were taken over 24 h. Urine samples were collected for up to 24 h and were assayed for theophylline and its major metabolites 1,3-dimethyluric acid (1,3-DMU), 1-methyluric acid (1-MU) and 3-methylxanthine (3-MX).[1] |
| 数据来源文献 | [1]. Kokufu, T., et al., Effects of lansoprazole on pharmacokinetics and metabolism of theophylline. Eur J Clin Pharmacol, 1995. 48(5): p. 391-5. [2]. Rupinder K Sodhi, et al. Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet. PLoS One. 2013 Jul 31;8(7):e70487. [3]. Jun Matsukawa, et al. A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands. Biochem Pharmacol. 2011 May 1;81(9):1145-51. |
| 单位 | 瓶 |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验炎性 IL -6 样细胞因子 Unpaired 2 和 3 (Upd2 和 Upd3),后者能够刺激肠干细胞增殖和上皮细胞再生。此外,Upd 家族蛋白也可通过受体 Dome 激活 JAK-STAT 信号通路。后续的实验也证明了这一点:他们使用 2xSTAT::GFP 报告系统来检测 JAK-STAT 通路的活性,结果发现,在 Ecc15 感染 4 小时后,肠道上皮被破坏,大脑中 GFP 表达上调。在神经胶质标记阳性的大脑稀疏细胞群中观察到 JAK-STAT 活性。进一步的研究发现,在果蝇胶质
生长。 ING4表达受抑制的细胞植入后,生长速度远远快于正常的对照肿瘤,并发展出更复杂的血管网络。而过量表达ING4的细胞植入后,肿瘤生长速度和血管生长速度都放慢。进一步用高级成像技术检查证实ING4的抑制与更成熟、更复杂的血管网络伴随出现,而过量表达则显著抑制血管发育。 另一组实验表明,ING4 抑制一种称为NF-kappa B的蛋白活动,NF-kappa B已知能刺激在多种癌症中过量表达的基因。ING4抑制因子的丧失引起对NF-kappa-B敏感的基因--干扰素8(Il-8)基因的过量
异型(isoform);3)CD2和CD2R是识别同一个分子上不同的表位;4)CD49已进一步划分为CD49a、CD49b、CD49c、CD49d、CD49e和CD49f,它们的基因定位于不同的染色体上,但具有较高的同源性。 (4)CD九个组划分的特异性是相对的,实际上,许多CD抗原的组织细胞分布较为广泛。此外,有的CD抗原可由不同的分类角度而归入不同的组,如IL-2受体a链CD25是活化T细胞的标记,也属于细胞因子受体;再如某些属于T细胞、B细胞、髓系细胞或NK细胞组的CD抗原实际
技术资料暂无技术资料 索取技术资料










